
Active Pharmaceutical Ingredients (API) for research
Active Pharmaceutical Ingredients (APIs) are the substances in drugs responsible for their therapeutic effects. In this section, you will find a wide variety of APIs intended for research use. These compounds are essential for the development, testing, and validation of new pharmaceutical formulations. CymitQuimica offers high-quality APIs to support research in drug discovery and development.
Subcategories of "Active Pharmaceutical Ingredients (API) for research"
Agn 194204 and Impurities
Allura Red Ac and Impurities
Amg 900 and Impurities
Astragaloside Iv and Impurities
Azd3965 and Impurities
Bal30072 and Impurities
Baz2-Icr and Impurities
Bdp9066 and Impurities
Bi-6C9 and Impurities
Bromodomain(Brd) Protein Inhibitors and Impurities
Cay10606 and Impurities
Cid 797718 and Impurities
Ctx and Impurities
Ddt and Impurities
Dementia treatment
Dermatitis treatment
Dtpa and Impurities
Ethopropazine Hcl and Impurities
Evt-401 and Impurities
Ff-Mas and Impurities
Foy 251 and Impurities
Gdc-0623 and Impurities
Glp-1 Receptor Agonists and Impurities
Gne-0723 and Impurities
Gnf179 and Impurities
Gpr17 and Impurities
Hbi-800 and Impurities
Mcc950 and Impurities
Menthone and Impurities
Mesalamine and Impurities
Methoxsalen and Impurities
Mgb-Bp-3 and Impurities
N’-Nitrosopentyl-3-(Picolyl) Amine and Impurities
Pinoxaden and Impurities
Piperonyl Butoxide and Impurities
Piperovatine and Impurities
Piretanide and Impurities
Pirlindole and Impurities
Plitidepsin and Impurities
Polybutylene Terephthalate and Impurities
Polyoxyethylene and Impurities
Polyunsaturated Fatty Acid (Pufa) and Impurities
Primapterin and Impurities
Procumbide and Impurities
Propanol and Impurities
Proparacaine and Impurities
Propargyl Alcohol and Impurities
Propofol and Impurities
Prucalopride and Impurities
Psilocin and Impurities
Valganciclovir and Impurities
Valproic Acid and Impurities
Velpatasvir and Impurities
Zinterol and Impurities
Zolmitriptan and Impurities
Show 47 more subcategories
Products of "Active Pharmaceutical Ingredients (API) for research"

Ref: 10-F035031
1g | Discontinued | Request information | |
2g | Discontinued | Request information | |
250mg | Discontinued | Request information |

2-(1,4-Diazepan-1-yl)-1-(piperidin-1-yl)ethan-1-one
Ref: 10-F728453
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
10g | Discontinued | Request information | |
500mg | Discontinued | Request information |

Ref: 10-F525176
1g | Discontinued | Request information | |
2g | Discontinued | Request information | |
5g | Discontinued | Request information | |
10g | Discontinued | Request information |

Ref: 10-F659871
1g | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |

Ref: 10-F478504
1g | Discontinued | Request information | |
2g | Discontinued | Request information | |
250mg | Discontinued | Request information |

1-Benzyl 4-(tert-butyl) (R)-5-methyl-1,4-diazepane-1,4-dicarboxylate
Ref: 10-F621729
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |

Ref: 10-F714229
1g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |

Ref: 10-F674887
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |

Methyl 3-(5-oxo-7-phenyl-1,4-diazepan-1-yl)propanoate
Ref: 10-F713507
1g | Discontinued | Request information |

tert-butyl 4-{5-cyano-[2,2'-bipyridine]-6-yl}-1,4-diazepane-1-carboxylate
Ref: 10-F526582
1g | Discontinued | Request information | |
10g | Discontinued | Request information |

1-(4-Methyl-1,3-thiazol-2-yl)-1,4-diazepane
Ref: 10-F665520
1g | Discontinued | Request information | |
50mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |

4-(2-Nitro-4-trifluoromethyl-phenyl)-[1,4]diazepane-1-carboxylic acidtert-butylester
Ref: 10-F478505
1g | Discontinued | Request information | |
2g | Discontinued | Request information | |
5g | Discontinued | Request information | |
250mg | Discontinued | Request information |

1-[6-(trifluoromethyl)pyridin-2-yl]-1,4-diazepane
Ref: 10-F518410
1g | Discontinued | Request information |

Ref: 10-F715134
1g | Discontinued | Request information | |
2.5g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |

1-(2-pyridin-4-ylethyl)-1,4-diazepane
Ref: 10-F307281
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
250mg | Discontinued | Request information |

Ref: 10-F085516
1g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |

2-Amino-1-(4-methyl-[1,4]diazepan-1-yl)-ethanone
Ref: 10-F085048
500mg | Discontinued | Request information |

Ref: 10-F712546
1g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |

Ref: 10-F711857
1g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |

3-(4-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)-1,4-diazepan-1-yl)propanoic acid
Ref: 10-F776456
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
10g | Discontinued | Request information |